释义 |
- Most common disorders
- Full genetic disorders list
- References
- Further reading
{{medical citations needed|date=November 2017}}The following is a list of genetic disorders and if known, type of mutation and the chromosome involved. Although the parlance "disease-causing gene" is common, it is the occurrence of an abnormality in these genes that causes the disease. Most common disorders- P – Point mutation, or any insertion/deletion entirely inside one gene
- D – Deletion of a gene or genes
- C – Whole chromosome extra, missing, or both (see chromosome abnormality)
- T – Trinucleotide repeat disorders: gene is extended in length
Disorder | Chromosome | Mutation |
---|
22q11.2 deletion syndrome | 22q | D | Angelman syndrome | 15 | DCP | Canavan disease | 17p | Charcot–Marie–Tooth disease | 17 | Color blindness | X | P | Cri du chat | 5 | D | Cystic fibrosis | 7q | P | Down syndrome | 21 | C | Duchenne muscular dystrophy | Xp | D | Familial hypercholesterolemia | 19 | P | Haemochromatosis | 6 | P | Haemophilia | X | P | Klinefelter syndrome | X | C | Neurofibromatosis | 17q/22q/? | Phenylketonuria | 12q | P | Polycystic kidney disease | 16 (PKD1) or 4 (PKD2) | P | Prader–Willi syndrome | 15 | DCP | Sickle cell disease | 11p | P | Spinal muscular atrophy | 5q | DP | Tay–Sachs disease | 15 | P | Turner syndrome | X | C |
Full genetic disorders listDisorder | Chromosome or gene | Type | prevalence (approx.) | 1p36 deletion syndrome | 1p36 | D | 1:7500 | 18p deletion syndrome | 18p | D | 21-hydroxylase deficiency | 6p21.3 | recessive | Alpha 1-antitrypsin deficiency | 14q32 | AAA syndrome (achalasia–addisonianism–alacrima syndrome) | AAAS | Aarskog–Scott syndrome | FGD1 | ABCD syndrome | EDNRB | recessive | Aceruloplasminemia | CP (3p26.3) | recessive | Acheiropodia | LMBR1 | recessive | Achondrogenesis type II | COL2A1 (12q13.11) | dominant | achondroplasia | FGFR3 (4p16.3) | dominant | Acute intermittent porphyria | HMBS | dominant and recessive forms | adenylosuccinate lyase deficiency | ADSL | recessive | Adrenoleukodystrophy | ABCD1 (X) | recessive | Alagille syndrome | JAG1, NOTCH2 | dominant | 1:100000 | ADULT syndrome | TP63 | dominant | Aicardi–Goutières syndrome | TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, IFIH1 | Albinism | Alexander disease | GFAP | alkaptonuria | HGD | Alport syndrome | 10q26.13 | Alternating hemiplegia of childhood | ATP1A3 | Amyotrophic lateral sclerosis – Frontotemporal dementia | C9orf72, SOD1, FUS, TARDBP, CHCHD10, MAPT | Alström syndrome | ALMS1 | Alzheimer's disease | PSEN1, PSEN2, APP, APOEε4 | Amelogenesis imperfecta | Aminolevulinic acid dehydratase deficiency porphyria | ALAD | Androgen insensitivity syndrome | Angelman syndrome | UBE3A | Apert syndrome | FGFR2 | Arthrogryposis–renal dysfunction–cholestasis syndrome | VPS33B | Ataxia telangiectasia | ATM | Axenfeld syndrome | PITX2, FOXO1A, FOXC1, PAX6 | Beare–Stevenson cutis gyrata syndrome | 10q26, FGFR2 | Beckwith–Wiedemann syndrome | IGF-2, CDKN1C, H19, KCNQ1OT1 | Benjamin syndrome | biotinidase deficiency | BTD | Björnstad syndrome | BCS1L | Bloom syndrome | 15q26.1 | Birt–Hogg–Dubé syndrome | 17 FLCN | Brody myopathy | ATP2A1 | Brunner syndrome | MAOA | CADASIL syndrome | NOTCH3 | P | CARASIL syndrome | HTRA1 | Chronic granulomatous disorder | Campomelic dysplasia | X 17q24.3–q25.1 | C | Canavan disease | ASPA | Carpenter Syndrome | RAB23 | |
Cerebral dysgenesis–neuropathy–ichthyosis–keratoderma syndrome (SEDNIK) | SNAP29 | Cystic fibrosis | CFTR (7q31.2) | D or S | [1] | Charcot–Marie–Tooth disease | PMP22, MFN2 | CHARGE syndrome | CHD7 | Chédiak–Higashi syndrome | LYST | recessive | Cleidocranial dysostosis | RUNX2 | Cockayne syndrome | ERCC6, ERCC8 | Coffin–Lowry syndrome | X RPS6KA3 | Cohen syndrome | COH1 | collagenopathy, types II and XI | COL11A1, COL11A2, COL2A1 | Congenital insensitivity to pain with anhidrosis (CIPA) | NTRK1 | Cornelia de Lange syndrome (CDLS) | HDAC8, SMC1A, NIPBL, SMA3, RAD21 | Cowden syndrome | PTEN | CPO deficiency (coproporphyria) | CPOX | Cranio-lenticulo-sutural dysplasia | 14q13–q21 | Cri du chat | 5p | D | Crohn's disease | 16q12 | P | Crouzon syndrome | FGFR2, FGFR3 | Crouzonodermoskeletal syndrome (Crouzon syndrome with acanthosis nigricans) | FGFR3 | Darier's disease | ATP2A2 | Dent's disease (Genetic hypercalciuria) | Xp11.22 CLCN5, OCRL | Denys–Drash syndrome | WT1 | De Grouchy syndrome | 18q | D | Down Syndrome | 21 | C | Di George's syndrome | 22q11.2 | D | Distal hereditary motor neuropathies, multiple types | HSPB8, HSPB1, HSPB3, GARS, REEP1, IGHMBP2, SLC5A7, DCTN1, TRPV4, SIGMAR1 | Dravet syndrome | SCN1A, SCN2A | Edwards Syndrome | 18 | trisomy | Ehlers–Danlos syndrome | COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, TNXB, ADAMTS2, PLOD1, B4GALT7, DSE | dominant | Emery–Dreifuss syndrome | EMD, LMNA, SYNE1, SYNE2, FHL1, TMEM43 | Erythropoietic protoporphyria | FECH | Fanconi anemia (FA) | FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM, FANCN, FANCP, FANCS, RAD51C, XPF | Fabry disease | GLA (Xq22.1) | P | Factor V Leiden thrombophilia | Fatal familial insomnia | PRNP | dominant | Familial adenomatous polyposis | APC | Familial dysautonomia | IKBKAP | Familial Creutzfeld–Jakob Disease | PRNP | dominant | Feingold syndrome | MYCN | FG syndrome | MED12 | Fragile X syndrome | FMR1 | T | Friedreich's ataxia | FXN T | G6PD deficiency | Galactosemia | GALT, GALK1, GALE | Gaucher disease | GBA (1) | Gerstmann–Sträussler–Scheinker syndrome | PRNP | dominant | Gillespie syndrome | PAX6 | Glutaric aciduria, type I and type 2 | GCDH, ETFA, ETFB, ETFDH | recessive | GRACILE syndrome | BCS1L | Griscelli syndrome | MYO5A, RAB27A, MLPH | Hailey–Hailey disease | ATP2C1 (3) | Harlequin type ichthyosis | ABCA12 | Hemochromatosis, hereditary | HFE, HAMP, HFE2B, TFR2, TF, CP | Hemophilia | FVIII | Hepatoerythropoietic porphyria | UROD | Hereditary coproporphyria | 3q12 | P | Hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu syndrome) | ENG, ACVRL1, MADH4 | Hereditary inclusion body myopathy | GNE, MYHC2A, VCP, HNRPA2B1, HNRNPA1 | Hereditary multiple exostoses | EXT1, EXT2, EXT3 | Hereditary spastic paraplegia (infantile-onset ascending hereditary spastic paralysis) | Hermansky–Pudlak syndrome | HPS1, HPS3, HPS4, HPS5, HPS6, HPS7, AP3B1 | Hereditary neuropathy with liability to pressure palsies (HNPP) | PMP22 | Heterotaxy | NODAL, NKX2-5, ZIC3, CCDC11, CFC1, SESN1 | Homocystinuria | CBS (gene) | recessive | [2] | Huntington's disease | HD | T | Hunter syndrome | IDS | Hurler syndrome | IDUA | Hutchinson–Gilford progeria syndrome | LMNA | Hyperlysinemia | AASS | recessive | Hyperoxaluria, primary | AGXT, GRHPR, DHDPSL | Hyperphenylalaninemia | 12q | Hypoalphalipoproteinemia (Tangier disease) | ABCA1 | Hypochondrogenesis | COL2A1 | Hypochondroplasia | FGFR3 (4p16.3) | Immunodeficiency–centromeric instability–facial anomalies syndrome (ICF syndrome) | 20q11.2 | Incontinentia pigmenti | IKBKG (Xq28) | P | Ischiopatellar dysplasia | TBX4 | dominant | Isodicentric 15 | 15q11–14 | Inv dup | Jackson–Weiss syndrome | FGFR2 | Joubert syndrome | INPP5E, TMEM216, AHI1, NPHP1, CEP290, TMEM67, RPGRIP1L, ARL13B, CC2D2A, OFD1, TMEM138, TCTN3, ZNF423, AMRC9 | Juvenile primary lateral sclerosis (JPLS) | ALS2 | Keloid disorder | Kniest dysplasia | COL2A1 | Kosaki overgrowth syndrome | PDGFRB | Krabbe disease | GALC | Kufor–Rakeb syndrome | ATP13A2 | LCAT deficiency | LCAT | Lesch–Nyhan syndrome | HPRT (X) | Li–Fraumeni syndrome | TP53 | Lynch syndrome | MSH2, MLH1, MSH6, PMS2, PMS1, TGFBR2, MLH3 | lipoprotein lipase deficiency | recessive | Malignant hyperthermia | RYR1 (19q13.2) | dominant | Maple syrup urine disease | BCKDHA, BCKDHB, DBT, DLD | recessive | Marfan syndrome | 15 | dominant | Maroteaux–Lamy syndrome | ARSB | recessive | McCune–Albright syndrome | 20 q13.2–13.3 | McLeod syndrome | XK (X) | MEDNIK syndrome | AP1S1 | D | [3][4] | Mediterranean fever, familial | MEFV | Menkes disease | ATP7A (Xq21.1) | Methemoglobinemia | Methylmalonic acidemia | MMAA, MMAB, MMACHC, MMADHC, LMBRD1, MUT | recessive | Micro syndrome | RAB3GAP (2q21.3) | Microcephaly | ASPM (1q31) | P | Morquio syndrome | GALNS, GLB1 | Mowat–Wilson syndrome | ZEB2 (2) | Muenke syndrome | FGFR3 | Multiple endocrine neoplasia type 1 (Wermer's syndrome) | MEN1 | dominant | Multiple endocrine neoplasia type 2 | RET | dominant | Muscular dystrophy | Muscular dystrophy, Duchenne and Becker type | Myostatin-related muscle hypertrophy | MSTN | myotonic dystrophy | DMPK, CNBP | dominant or T | Natowicz syndrome | HYAL1 | Neurofibromatosis type I | 17q11.2 | Neurofibromatosis type II | Niemann–Pick disease | SMPD1, NPA, NPB, NPC1, NPC2 | Nonketotic hyperglycinemia | GLDC, AMT, GCSH | recessive | Nonsyndromic deafness | Noonan syndrome | PTPN11, KRAS, SOS1, RAF1, NRAS, HRAS, BRAF, SHOC2, MAP2K1, MAP2K2, CBL | dominant | Norman–Roberts syndrome | RELN | recessive | Ogden syndrome | X | P | Omenn syndrome | RAG1, RAG2 | recessive | Osteogenesis imperfecta | COL1A1, COL1A2, IFITM5 | dominant | Pantothenate kinase-associated neurodegeneration | PANK2 (20p13–p12.3) | recessive | Patau syndrome (Trisomy 13) | 13 | trisomy | PCC deficiency (propionic acidemia) | PC | recessive | Porphyria cutanea tarda (PCT) | UROD | dominant | Pendred syndrome | PDS (7) | recessive | Peutz–Jeghers syndrome | STK11 | dominant | Pfeiffer syndrome | FGFR1, FGFR2 | dominant | Phenylketonuria | PAH | recessive | Pipecolic acidemia | AASDHPPT | recessive | Pitt–Hopkins syndrome | TCF4 (18) | dominant, de novo | Polycystic kidney disease | PKD1 (16) or PKD2 (4) | P | Polycystic ovary syndrome (PCOS) | Porphyria | Prader–Willi syndrome | 15 | paternal imprinting | Primary ciliary dyskinesia (PCD) | DNAI1, DNAH5, TXNDC3, DNAH11, DNAI2, KTU, RSPH4A, RSPH9, LRRC50 | recessive | Primary pulmonary hypertension | Protein C deficiency | PROC | dominant | [5] | Protein S deficiency | PROS1 | dominant | Pseudo-Gaucher disease | Pseudoxanthoma elasticum | ABCC6 | recessive | Retinitis pigmentosa | RP1, RP2, RPGR, PRPH2, IMPDH1, PRPF31, CRB1, PRPF8, TULP1, CA4, HPRPF3, ABCA4, EYS, CERKL, FSCN2, TOPORS, SNRNP200, PRCD, NR2E3, MERTK, USH2A, PROM1, KLHL7, CNGB1, TTC8, ARL6, DHDDS, BEST1, LRAT, SPARA7, CRX | dominant or recessive | Rett syndrome | MECP2 | dominant, often de novo | Roberts syndrome | ESCO2 | recessive | Rubinstein–Taybi syndrome (RSTS) | CREBBP | dominant | Sandhoff disease | HEXB | recessive | Sanfilippo syndrome | SGSH, NAGLU, HGSNAT, GNS | Schwartz–Jampel syndrome | HSPG2 | recessive | Spondyloepiphyseal dysplasia congenita (SED) | COL2A1 | dominant | Shprintzen–Goldberg syndrome | FBN1 | dominant | Sickle cell anemia | 11p15 | P | Siderius X-linked mental retardation syndrome | Xp11.22, PHF8 | PD | Sideroblastic anemia | ABCB7, SLC25A38, GLRX5 | recessive | Sly syndrome | GUSB | recessive | Smith–Lemli–Opitz syndrome | DHCR7 | recessive | Smith–Magenis syndrome | 17p11.2 | dominant | Spinal muscular atrophy | 5q | Spinocerebellar ataxia (types 1–29) | ATXN1, ATXN2, ATXN3, PLEKHG4, SPTBN2, CACNA1A, ATXN7, ATXN8OS, ATXN10, TTBK2, PPP2R2B, KCNC3, PRKCG, ITPR1, TBP, KCND3, FGF14 | dominant, recessive or T | SSB syndrome (SADDAN) | FGFR3 | dominant | Stargardt disease (macular degeneration) | ABCA4, CNGB3, ELOVL4, PROM1 | dominant or recessive | Stickler syndrome (multiple forms) | COL11A1, COL11A2, COL2A1, COL9A1 | dominant or recessive | Strudwick syndrome (spondyloepimetaphyseal dysplasia, Strudwick type) | COL2A1 | dominant | Tay–Sachs disease | HEXA (15) | recessive | Tetrahydrobiopterin deficiency | GCH1, PCBD1, PTS, QDPR, MTHFR, DHFR | recessive | Thanatophoric dysplasia | FGFR3 | dominant | Treacher Collins syndrome | 5q32–q33.1 (TCOF1, POLR1C, or POLR1D) | dominant | Tuberous sclerosis complex (TSC) | TSC1, TSC2 | dominant | Turner syndrome | X | monosomy | Usher syndrome | MYO7A, USH1C, CDH23, PCDH15, USH1G, USH2A, GPR98, DFNB31, CLRN1 | recessive | Variegate porphyria | PPOX | dominant | von Hippel–Lindau disease | VHL | dominant | Waardenburg syndrome | PAX3, MITF, WS2B, WS2C, SNAI2, EDNRB, EDN3, SOX10 | dominant | Weissenbacher–Zweymüller syndrome | COL11A2 | recessive | Williams syndrome | 7q11.23 | dominant | 1:10000 | Wilson disease | ATP7B | recessive | Woodhouse–Sakati syndrome | C2ORF37 (2q22.3–q35) | recessive | Wolf–Hirschhorn syndrome | 4p16.3 | dominant, often de novo | Xeroderma pigmentosum | 15 ERCC4 | recessive | X-linked mental retardation and macroorchidism (fragile X syndrome) | X | X-linked spinal-bulbar muscle atrophy (spinal and bulbar muscular atrophy) | X | Xp11.22 deletion | X CENPVL1, CENPVL2, GSPT2, MAGED1 | D | X-linked severe combined immunodeficiency (X-SCID) | X | X-linked sideroblastic anemia (XLSA) | ALAS2 (X) | 47,XXX (triple X syndrome) | X | C | XXXX syndrome (48, XXXX) | X | XXXXX syndrome (49, XXXXX) | X | XYY syndrome (47,XYY) | X | Zellweger syndrome | PEX1, PEX2, PEX3, PEX5, PEX6, PEX10, PEX12, PEX13, PEX14, PEX16, PEX19, PEX26 | recessive |
References1. ^{{cite web|url=https://www.cdc.gov/genomics/gtesting/ACCE/FBR/|title=FBR Model for Genetic Tests{{!}}ACCE{{!}}Genetic Testing{{!}}Genomics{{!}}CDC|website=www.cdc.gov|access-date=2017-10-24}} 2. ^{{cite web|url=https://omim.org/entry/236200|title=OMIM Entry – # 236200 – Homocystinuria Due to Cystathionine Beta-Synthase Deficiency|website=omim.org|access-date=2018-03-01}} 3. ^{{cite web|url=http://www.eurekalert.org/pub_releases/2008-12/plos-an120308.php|title='MEDNIK': A novel genetic syndrome|website=EurekAlert!|language=en|access-date=2017-10-24}} 4. ^http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20081204/Mutated_Gene_081204/20081204?hub=Health 5. ^{{cite web|url=https://omim.org/entry/176860|title=OMIM Entry – # 176860 – Thrombophilia Due to Protein C Deficiency, Autosomal Dominant; THPH3|website=omim.org|access-date=2018-03-01}}
Further reading- {{cite web|title=Specific Genetic Disorders|url=https://www.genome.gov/10001204/specific-genetic-disorders/|website=National Human Genome Research Institute (NHGRI)|publisher=genome.gov|accessdate=15 November 2017}}
- {{cite web|title=Congenital and Genetic Diseases {{!}} Genetic and Rare Diseases Information Center (GARD) – an NCATS Program|url=https://rarediseases.info.nih.gov/diseases/diseases-by-category/5/congenital-and-genetic-diseases|website=rarediseases.info.nih.gov|publisher=NIH.gov|accessdate=15 November 2017|language=en}}
{{Medicine|state=collapsed}} 3 : Lists of diseases|Genetic diseases and disorders|Medical lists |